The Level of Cytokeratin 18 in Patients with HIV and Viral Hepatitis C Co-Infection in Latvia

Aida, Y., Abe, H., Tomita, Y., Nagano, T., Seki, N., Sugita, T., Itagaki, M., Ishiguro, H., Sutoh, S., Aizawa, Y. (2014). Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease. Int. J. Clin. Exp. Med., 7 (11), 4191–4198.Search in Google Scholar

Apostolova, N., Gomez-Sucerquia, L. J., Gortat, A., Blas-Garcia, A., Esplugues, J. V. (2011). Compromising mitochondrial function with the antiretroviral drug efavirenz induces cell survival-promoting autophagy. Hepatology, 54 (3), 1009–1019.10.1002/hep.2445921626526Search in Google Scholar

Benmassaoud, A., Ghali, P., Cox, J., Wong, P., Szabo, J., Deschenes, M., Osikowicz, M., Lebouche, B., Klein, M. B., Sebastiani, G. (2018). Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection. PloS ONE, 13 (1), e0191985.10.1371/journal.pone.0191985579026029381754Search in Google Scholar

Blackard, J. T., Sherman, K. E. (2008). HCV/HIV co-infection: Time to re-evaluate the role of HIV in the liver? J. Viral Hepat., 15, 323–330.10.1111/j.1365-2893.2008.00970.x352683218208497Search in Google Scholar

Canbay, A., Friedman, S., Gores, G. J. (2004). Apoptosis: The nexus of liver injury and fibrosis. Hepatology, 39 (2), 273–278.10.1002/hep.2005114767974Search in Google Scholar

Chew, K. W., Bhattacharya, D. (2016). Virologic and immunologic aspects of HIV-HCV co-infection. AIDS, 30 (16), 2395–2404.10.1097/QAD.0000000000001203603938627427873Search in Google Scholar

Feldstein, A. E., Wieckowska,A., Lopez, A. R., Liu, Y.-C., Zein, N. N., McCullough, A. J. (2009). Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study. Hepathology, 50, 1072–1078.10.1002/hep.23050275751119585618Search in Google Scholar

Friedman, S. L. (2010). Evolving challenges in hepatic fibrosis. Nat. Rev. Gastroenterol. Hepatol., 7, 425–436.10.1038/nrgastro.2010.9720585339Search in Google Scholar

Ganesan, M., Dagur, R. S., Makarov, E., Poluektova, L. I., Kadambi, S., Osna, N. A. (2018). Matrix stiffness regulate apoptotic cell death in HIV-HCV co-infected hepatocytes: Importance for liver fibrosis progression. Biochem. Biophys. Res. Commun., 500, 717–722.10.1016/j.bbrc.2018.04.142686304929679566Search in Google Scholar

Guicciardi, M. E., Gores, G. J. (2005). Apoptosis: A mechanism of acute and chronic liver injury. Gut, 54, 1024–1033.10.1136/gut.2004.053850177460115951554Search in Google Scholar

Hong, F., Tuyama, A., Lee, T. F., Loke, J., Agarwal, R., Cheng, X., Garg, A., Fiel, M. I., Schwartz, M., Walewski, J., Branch, A., Schecter, A. D., Bansa, M. B. (2009). Hepatic stellate cells express functional CXCR4: Role in stromal cell-derived factor-1alphamediated stellate cell activation. Hepatology, 49, 2055–2067.10.1002/hep.22890289354719434726Search in Google Scholar

Hong, F., Saiman, Y., Si, C., Mosoian, A., Bansal, M. B. (2012). X4 Human iImmunodeficiency virus Type 1 gp120 promotes human hepatic stellate cell activation and collagen I expression through interactions with CXCR4. PLoS One, 7, e33659.10.1371/journal.pone.0033659Search in Google Scholar

Kaspar, M. B., Sterling, R. K. (2017). Mechanisms of liver disease in patients infected with HIV. BMJ Open Gastro., 4, e000166.10.1136/bmjgast-2017-000166566326329119002Search in Google Scholar

Kim, H. N., Nance, R., Rompaey, S. V., Delaney, J. C., Crane, H. M., Cachay, E. R., Geng, E., Boswell, S. L., Rodriguez, B., Eron, J., Saag, M., Moore, R. D., Kitahata, M. M. (2016). Poorly controlled HIV infection: An independent risk factor for liver fibrosis. J. Acquir. Immune Defic. Syndr., 72 (4), 437–443.10.1097/QAI.0000000000000992492518926990826Search in Google Scholar

Kliemann, D. A., Wolff, F. H., Tovo, C. V., Alencastro, P. R., Ikeda, M. L. R., Brandćo, A. B. M., Barcellos, N., Fuchs, S. C. (2016). Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients. Ann. Hepatol., 15 (1), 27–32.10.5604/16652681.118419726626637Search in Google Scholar

Chu, P. G., Weiss, L. M. (2002). Keratin expression in human tissues and neoplasms. Histopathology, 40, 403–439.10.1046/j.1365-2559.2002.01387.x12010363Search in Google Scholar

Kobayashi, N., Kumada, T., Toyoda, H., Tada, T., Ito, T., Kage, M., Okanoue, T., Kudo, M. (2017). Ability of cytokeratin-18 fragments and FIB4 index to diagnose overall and mild fibrosis nonalcoholic steatohepatitis in Japanese nonalcoholic fatty liver disease patients. Digestive Dis., 35 (6), 521–530.10.1159/00048014229040984Search in Google Scholar

Larrousse, M., Laguno, M., Segarra, M., De Lazzari, E., Martínez, E., Luis Blanco, J. L., León, A., Deulofeu, R., Miquel, R., Milinkovic, A., Lonca, M., Miró, J. M., Biglia, A., Murillas, J., Gatell, J. M., Mallolas, J. (2007). Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients. J. Acquir. Immune Defic. Syndr., 46, 304–311.10.1097/QAI.0b013e318152050218172937Search in Google Scholar

de Lédinghen, V., Barreiro, P., Foucher, J., Labarga, P., Castéra, L., Vispo, M. E., Bernard, P.-H., Martin-Carbonero, L., Neau, D., García-Gascó, P., Merrouche, W., Soriano, V. (2008). Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy. J. Viral Hepat., 15, 427–433.10.1111/j.1365-2893.2007.00962.x18221303Search in Google Scholar

Maagaard, A., Kvale, D., Scand, J. (2009). Long term adverse effects related to nucleoside reverse transcriptase inhibitors: Clinical impact of mitochondrial toxicity. Infect Dis, 41 (11–12), 808–817.10.3109/00365540903186181Search in Google Scholar

Macías, J., Japón, M. A., Sáez, C., Palacios, R. B., Mira, J. A., García-García, J. A., Merchante, N., Vergara, S., Lozano, F., Gómez-Mateos, J., Pineda, J. A. (2005). Increased hepatocyte Fas expression and apoptosis in HIV and hepatitis C virus co-infection. J. Inf. Dis., 192, 1566–1576.10.1086/49173616206071Search in Google Scholar

Madelāne, M., Krūmiņa, A., Sīmanis, R., Šķenders, Ģ., Ivanovs, A., Stūre, G., Vīksna, L. (2019). Difference in markers of microbial translocation and cell apoptosis in HIV monoinfected and HIV/HCV coinfected patients. Proc. Latvian Acad. Sci., Section B, 73 (4), 304–311.10.2478/prolas-2019-0048Search in Google Scholar

Marchetti, G., Tincati, C., Silvestri, G. (2013). Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin. Microbiol. Rev., 26, 2–18.10.1128/CMR.00050-12355366823297256Search in Google Scholar

Mohsen, A. H., Easterbrook, P. J., Taylor, C., Portmann, B., Kulasegaram, R., Murad, S., Wiselka, M., Norris, S. (2003). Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut, 52, 1035–1040.10.1136/gut.52.7.1035Search in Google Scholar

Neuman, M. G., Cohen, L. B., Nanaua R. M. (2016). Hyaluronic acid as a non-invasive biomarker of liver fibrosis. Clin. Biochem., 49, 302–315.10.1016/j.clinbiochem.2015.07.019Search in Google Scholar

Noguchi, K., Gel, Y. R., Brunner, E., Konietschke, F. (2012). nparLD: An R software package for the nonparametric analysis of longitudinal data in factorial experiments. J. Statist. Software, 50 (12), 1–23.10.18637/jss.v050.i12Search in Google Scholar

Nunes, D., Fleming, C., Offner, G., Craven, D., Fix, O., Heeren, T., Koziel, M. J., Graham, C., Tumilty, S., Skolnik, P., Stuver, S., Horsburgh Jr, C. R., Cotton, D. (2010). Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Amer. J. Gastroenterol., 105, 1346–1353.10.1038/ajg.2009.746Search in Google Scholar

Parfieniuk-Kowerda, A., Lapinski, T. W., Rogalska-Plonska, M., Swiderska, M., Panasiuk, A., Jaroszewicz, J., Flisiak, R. (2014). Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C. Liver Int, 34, 544–550.10.1111/liv.12297Search in Google Scholar

Platt, L., Easterbrook, P., Gower, E., McDonald, B., Sabin, K., McGowan, C., Yanny, Razavi, H., Vickerman, P. (2016). Prevalence and burden of HCV co-infection in people living with HIV: A global systematic review and meta-analysis. Lancet Infect. Dis., 16, 797–808.10.1016/S1473-3099(15)00485-5Search in Google Scholar

Rockstroh, J. K., Peters, L., Grint, D., Soriano, V., Reiss, P., Monforte, Ad., Beniowski, M., Losso, M. H., Kirk, O., Kupfer, B., Mocroft, A., for EuroSIDA in EuroCoord. (2013). Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV? J. Hepatol., 59 (2), 213–220.10.1016/j.jhep.2013.04.00523583272Search in Google Scholar

Rohrbach, J., Stickel, F., Schmid, P., Thormann, W., Kovali, H., Scherrer, A., Günthard, H. F., Vuichard, D., Cavassini, M., Ambrosioni, J., Bernasconi, E., Furrer, H., Rauch, A. and the Swiss HIV Cohort Study. (2013). Changes of biomarkers of liver disease during successful combination antiretroviral theraly in HIV/HCV-coinfected individuals. Antiviral Ther.,19, 149–159.10.3851/IMP268624036684Search in Google Scholar

Scherzer, R., Heymsfield, S. B., Rimlanda, D., Rimlanda, D., Powdwrly, W. G., Tien, P. C., Bacchetti, P., Shlipak, M. G., Grunfeld, C. (2017). Association of serum albumin and AST with 5-year all-cause mortality in HIV/HCV coinfection and HIV monoinfection. AIDS, 31 (1), 71–79.10.1097/QAD.0000000000001278512777527677166Search in Google Scholar

Schmid, P., Bregenzer, A., Huber, M., Rauch, A., Jochum, W., Müllhaupt, B., Vernazza, P., Opravil, M., Weber, R., Swiss HIV Cohort Study. (2015). Progression of liver fibrosis in HIV/HCV co-infection: A comparison between non-invasive assessment methods and liver biopsy. PLoS ONE, 10 (9), e0138838.10.1371/journal.pone.0138838458785926418061Search in Google Scholar

Selvaraj, S., Ghebremichael, M., Li, M., Foli, Y., Langs-Barlow, A., Ogbuagu, A., Barakat, L., Tubridy, E., Edifor, R., Lam, W., Cheng, Y.-C., Paintsil, E. (2014). Antiretroviral therapy-induced mitochondrial toxicity: Potential mechanisms beyond polymerase-ć inhibition. Clin. Pharmacol. Ther., 96 (1), 110–120.10.1038/clpt.2014.64406519524637942Search in Google Scholar

Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Cassia, M., Correa, M. C., Montaner, J., Sulkowski, M. S., Torriani, F. J., Dieterich, D. T., Thomas, D. L., Messinger, D., Nelson, M. for the APRICOT Clinical Investigators. (2006). Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV co-infection. Hepatol. Baltim. Md, 43, 1317–1325.10.1002/hep.2117816729309Search in Google Scholar

Vīksna, L., Keišs, J., Sočņevs, A., Rozentāle, B., Pilmane, M., Sevastjanova N., Buiíe, I., Jēruma, A., Eglīte, J., Ābeltiņa K., Sondore, V. (2009). Novel laboratory tests in assessment of liver function and acute and chronic viral liver diseases. Proc. Latvian Acad. Sci., Section B, 63 (4/5), 228–233.10.2478/v10046-009-0035-4Search in Google Scholar

Vīksna, L., Ekšteina, I., Madelāne, M., Zeltiņa, I., Krūmiņa, A., Koļesovs, A., Simanis, R. (2019). Markers of liver fibrosis and apoptosis in patients with HIV mono-infection and HIV/HCV co-infection. HIV AIDS Rev., 18 (1), 33–39.10.5114/hivar.2019.84198Search in Google Scholar

Wilen, C. B., Tilton, J. C., Doms, R. W. (2012). HIV: Cell binding and entry. Cold Spring Harb. Perspect. Med., 2:a006866.10.1101/cshperspect.a006866Search in Google Scholar